Adaptimmune Therapeutics plc ADR (ADAP)
Market Closed
7 Aug, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 03
-0
-3.2258%
$
75.16M Market Cap
- P/E Ratio
- Div Yield
125,818 Volume
-0.44 Eps
$ 0.03
Previous Close Want to track ADAP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Adaptimmune Therapeutics plc ADR (ADAP) Statistics
Valuation metrics
Market Cap 75.16M
Enterprise value 97.78M
Trailing P/E (ttm) -0.16
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 3.59
Price/Book (mrq) -0.18
Enterprise Value/Revenue 4.66
Enterprise Value/EBITDA -1.42
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 274.22K
Average volume (90 days) 497.59K
Price summary
52-Week low 0
52-Week high 0.28
Beta -
50-Day moving average 0.03
200-Day moving average 0.02
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -3.72%
Operating margin -3.63%
Operational effectiveness
Return on assets -0.6%
Return on equity 1.44%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.08
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.3
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.1
Total debt (mrq) -
Total Debt/Equity (mrq) -0.69
Current ratio (mrq) 1.52%
Book value per share (mrq) -0.27
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
